Viewing Study NCT02458235


Ignite Creation Date: 2025-12-24 @ 10:45 PM
Ignite Modification Date: 2026-01-26 @ 4:20 PM
Study NCT ID: NCT02458235
Status: COMPLETED
Last Update Posted: 2020-10-12
First Post: 2015-01-05
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: Donor Lymphocyte Infusion With Azacitidine to Prevent Hematologic Malignancy Relapse After Stem Cell Transplantation
Sponsor: University of California, San Francisco
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Acute Myelogenous Leukemia View
None Acute Lymphoid Leukemia View
None Juvenile Myelomonocytic Leukemia View
None Myelodysplastic Syndrome View
Keywords:

Keywords

Keyword Brief Keyword Text View
None pediatric leukemia myelodysplastic syndrome azacitidine View